In order to maintain body weight regulation, leptin directly or indirectly signals nutritional changes to key organs, but little is known about its target genes in human adipose tissue. Leptin receptor loss of function is a unique way to explore the role of leptin in the regulation of adipose tissue. OBJECTIVE: We studied the consequences of the absence of leptin signaling on adipocyte gene expression in two girls with a mutation in the leptin receptor. The expression levels of the ob gene and adipocyte transcription factors (SREBP1c, C=EPBa, b, PPARg1, g2) were quantified by RT-PCR in subcutaneous adipose tissue of these patients and of 10 morbidly obese women. RESULTS: Ob mRNA levels in subjects lacking the leptin receptor were not overexpressed but were in the range that could be expected from their BMI (58 and 26 amol=mg total mRNA, range in obese women: 26 -69). Expression of the five transcription factors was also in the same range in the affected patients and in morbidly obese women (7.7 and 6.8 amol=mg total mRNA, range: 2.2 -9.4 for SREBP1c, 159 and 51 range: 51 -406 for C=EPBa, 6.1 and 3.3 range: 2.4 -24.8 for C=EPBb, 16.7 and 27.4 range: 9.4 -29.7 for PPARg1 and 1.7 and 5.4 amol=mg total mRNA range: 1.7 -8.8 for PPARg2). Significant correlation was found between the mRNA levels of leptin and PPARg2 and leptin and C=EBPa whereas no correlation was observed between leptin and SREBP1c, PPARg1, or C=EBPb mRNA levels. CONCLUSION: In patients lacking leptin signaling, the fact that ob gene expression is adequately adapted to their body fat mass argues against a direct negative feedback loop in the regulation of leptin expression in humans. The normal expression of several transcription factors, known to be dependent of the nutritional status, suggests that leptin is not a major contributor of their in vivo transcriptional regulation in human adipose tissue.
Introduction
Leptin is an adiposity signal with central as well as peripheral action 1 . The effects of leptin on food intake and on the reproductive function depends on brain neuropeptide circuits in the hypothalamus. 2, 3 Experimental studies also suggest a role for leptin on peripheral metabolism 4 and gene expression. 5, 6 Several studies suggested that leptin impairs insulin signaling, inhibits lipogenesis and stimulates lipolysis. 4 In mice adipose tissue, leptin has been shown to affect the expression of transcription factors (ie SREBP1c, PPARg) that participate in the regulation of the expression of several key genes of fatty acid and glucose metabolism. 5 At the present time, little is known about the in vivo metabolic effects of leptin on human adipocytes. The effects of a complete defect of leptin signaling on adipose tissue leptin synthesis, in other words the feedback of leptin on its adipocyte synthesis, have not been studied in humans.
Neither has the consequences of ineffective leptin signaling on human adipose tissue metabolism been studied. Mutations in the leptin or leptin receptor gene represent unique situations to study the role of leptin both at the central and peripheral levels. As initially observed in animals, humans with ineffective leptin signaling, either because they lack leptin or have a defective receptor, develop hyperphagia, morbid obesity and multiple endocrine abnormalities. 7, 8 We previously reported cases of obese individuals, with a complete absence of leptin signaling both at the central and peripheral level, due to a leptin receptor mutation. 8 The mutated gene encodes for a truncated leptin receptor lacking both transmembrane and intracellular domains. 8 Homozygous carriers of the mutation have extremely high circulating leptin concentrations (> 600 ng=ml), at least five to six times higher than expected for their degree of adiposity. 8 The high leptin concentrations in the blood of affected patients were shown to be related, at least in part, to a decreased clearance of circulating leptin due to its trapping by a serum leptinbinding factor containing the truncated receptor. 9 However, an over expression of the ob gene due to the complete absence of a direct negative feedback loop that may normally control the expression of the hormone might also be expected.
Despite their morbid obesity, patients with the leptin receptor loss of function may be considered in a 'starvationlike' metabolic situation due to the chronic absence of leptin signaling. Central pituitary abnormalities such as hypogonadism, hypothyroidism and a deficit of somatotropin secretion, observed in leptin receptor deficient patients, are classical neuro-endocrine consequences of starvation. Adipose tissue is highly sensitive to the nutritional status. Under condition of high energy intake, adipocytes store excess energy under triglycerides and the size and number of the adipose cells increases. 4 During starvation, adipose tissue releases fatty acids that provide energy to the other organs. These functions are tightly controlled and a large body of evidence supports a major role for leptin in this process, at least in rodents. At the molecular level, transcription factors (ie SREBP1c, PPARg) that participate in the regulation of the expression of several key genes of fatty acid and glucose metabolism, mediate the responses to nutritional change. 10, 11 Leptin has been shown to affect the expression of some of these factors in mice adipose tissue. 5 The aim of the present work was to analyze the consequences of the lack of leptin signaling on the functions of adipose tissue by investigating the expression levels of the ob gene and of several adipocyte transcription factors (SREBP1c, C=EBPa, C=EBPb, PPARg1 and PPARg2) in abdominal subcutaneous adipose tissue biopsies of two girls with the Ob-R mutation.
Subjects and methods

Patients and protocols
We previously described a mutation in the human leptin receptor gene in a consanguineous family of Algerian origin. The three girls had a similar phenotype of morbid obesity with an abnormal food intake behavior, associated with multiple endocrine dysfunctions. 8 The clinical characteristics of the two living affected sisters with the Ob-Rhd mutation (HD413 and HD416) and from ten Caucasian women with morbid obesity (body mass index > 40 kg=m 2 ) are presented in Table 1 . At the time of the study, all subjects were on their maximal peak weight and were not on a restrictive diet. Subcutaneous adipose tissues were obtained after an overnight fast on the first day of hospitalization in the department of Nutrition (Hôtel-Dieu, Paris). Adipose tissue samples (mean 327 AE 99 mg, range 159 -550 mg) were obtained by needle biopsies from the peri-umbilical area, under local anesthesia (1% xylocaiïne) and immediately frozen in liquid nitrogen and stored at À80 C until analysis. Although there are substantial challenges when trying to obtain accurate measurements of body fat mass in morbidly obese subjects, 12 we decided to evaluate the body composition by biphotonic absorptiometry (DXA, Hologic). During the examination, we took particular care to have the body of the subject lying in the window of DXA recording. Circulating leptin levels were measured as reported. 9 Informed personal and parental consents were obtained and the local Ethic Committee (CCPPRB, Hôtel-Dieu, Paris) granted ethical permission.
Total RNA preparation and mRNA quantification Adipose tissue samples were crushed in liquid nitrogen and total RNA was prepared using the RNeasy total RNA kit (Qiagen, Chatsworth, CA). The ratio of absorption (260=280 nm) of all preparations was between 1.9 and 2.0 and the mean yield of total RNA was 1.5 AE 0.4 mg per 100 mg of tissue (range 0.5 -2). Target mRNA concentrations were Gene expression in absence of leptin signaling K Clément et al measured using quantitative assays based on reverse transcription followed by competitive polymerase chain reaction (RT-cPCR) consisting of the co-amplification of cDNAs with known amounts of a specific competitor DNA in the same test tube. 13 The sequences of the PCR primers and the description of the competitors for the assays of leptin, SREBP1c and PPARg (g1 and g2) mRNAs have been reported previously. 14 -16 For C=EBPa and b mRNAs, new assays were developed. A 252 bp long C=EBPacDNA fragment was synthesized by RT-PCR from adipose tissue total RNA using 812 The RT reactions were performed from 0.1 mg of adipose tissue total RNA using a thermostable reverse transcriptase enzyme (Tth, Promega, Charbonières, France) and one of the specific antisense primers, under conditions that warrant optimal synthesis of the first strand cDNA. 13 Then, the reaction medium was added to a PCR mastermix, which was aliquoted into 4 tubes, each containing a different known amount of specific competitor. A CY-5 5 0 -labeled sense primer was used in the competitive PCRs and the fluorescent products were separated using polyacrylamide (4%) gel electrophoresis using an AlfExpress DNA sequencer (Pharmacia, Upsala, Sweden) and analyzed using the Fragment Manager software (Pharmacia). The mRNA concentration was determined at the competition equivalence point as previously described and validated. To ensure that the total RNA preparations from the different subjects could be compared, we also determined by RT-cPCR the mRNA levels of b-actin as a housekeeping gene marker.
Presentation of the results and statistical analysis
Target mRNA values are presented as absolute concentration in amol=ug (10 À18 m) of tissue total RNA. Significance of the correlation was examined using the Spearman's rank correlation test (P < 0.05 was the threshold for significance).
Results
Leptin gene expression in patients with the leptin receptor loss of function The adipose tissue leptin mRNA levels in HD413 and HD416 were 58 and 26 amol=mg total mRNA, respectively. These values did not differ from the leptin mRNA levels found in the adipose tissue of the 10 control morbidly obese women (mean ¼ 44 AE 15 amol=mg total RNA, range: 26 -69). There was also no difference when ob gene expression was corrected for b-actin mRNA levels. Leptin mRNA levels represented 0.15 AE 0.04% (range 0.09 -0.2) of b-actin mRNA abundance in the adipose tissue of the 10 morbidly obese women and 0.15% and 0.23% in HD413 and HD416, respectively. As shown in Figure 1 , leptin mRNA expression in abdominal subcutaneous adipose tissue was apparently related to the size of the fat deposit in the 10 control obese women, but the correlation (Rho ¼ 0.36) is not significant, which is probably due to the small sample size, the narrow range of BMI and an outlayer. When this subject was excluded, the relationship became highly significant (Rho ¼ 0.86, P < 0.001). Leptin mRNA levels in the subcutaneous fat of HD413 and HD416 were in the range that could be expected from their BMI, or even below when their body fat mass was taken into account ( Figure 1) . Therefore, leptin mRNA was not overexpressed in the adipose tissue of patients with a loss of function of the leptin receptor. Figure 2 shows the actual mRNA levels of the different genes that have been investigated in the present study. There were large differences in the expression levels of the different target genes. C=EBPa mRNA is the most abundant transcript and was about 25 fold more expressed than C=EBPb in the adipose tissue of obese women (185 AE 29 vs 8 AE 2 amol=mg total RNA for C=EBPa vs C=EBPb). SREBP1c and PPARg mRNA levels were in the ranges that have been previously reported for obese subjects, with PPARg2 representing only about 20% (22 AE 3%) of the total PPARg transcripts.
SREBP1c, PPARg, and C=EBPs gene expression
13,16
The expression of these genes in the adipose tissue of the two sisters with the Ob-R mutation was not different from (Figure 2 ). There was also no difference between the girls carrying the mutated leptin receptor and the other obese women when the data are expressed by reference to b-actin mRNA levels (data not shown). For SREBP1c, it seemed that 2 groups could be separated, one including 7 of the obese women with values ranging from 2.2 -3.9 amol=mg total mRNA, and the other, characterized by a slightly higher expression of SREBP1c, which included the two affected sisters (7.7 and 6.8 amol=mg total mRNA in HD413 and HD416, respectively) and two additional obese women (6.4 and 7.9 amol=mg total mRNA). Patients with increased levels of SREBP1c mRNA were some of the youngest investigated patients. Interestingly, we found a significant negative correlation between SREBP1c gene expression and the age of the subjects (Rho ¼ À0.69, P ¼ 0.019).
When taking into account the data from all the subjects, including the two affected sisters, significant correlations were found between the mRNA levels of leptin and PPARg2 (Rho ¼ 0.71, P ¼ 0.009) and leptin and C=EBPa (Rho ¼ 0.64, P ¼ 0.03). PPARg2 and C=EBPa mRNA levels were also positively correlated (Rho ¼ 0.61, P ¼ 0.04). There was no correlation between leptin and SREPB1c, PPARg1, or C=EBPb mRNA levels.
Discussion
This study was designed to analyze the effects of chronic ineffective leptin signaling on the gene expression of leptin and of several transcription factors, themselves participating in the expression of key genes of adipose tissue metabolism.
In patients with a mutation in the leptin receptor gene, we observed no significant change in the expression of the ob gene and of several key adipose transcription factors (SREBP1c, PPARg, C=EBPa and b) involved in adipocyte differentiation and metabolism. These data give new insight on the in vivo effect of leptin on adipose tissue metabolism in humans.
The identification of obese rodents and humans with leptin deficiency that can be powerfully treated by recombinant leptin is in agreement with the concept of an adipostatic loop controlling weight. 17, 18 Thus, in a situation of complete leptin resistance due to the leptin receptor mutation, we hypothesized an increased compensatory production of leptin by adipocyte cells due to reduced efficiency in a feedback loop. We suggested that the increased expression of the ob gene would contribute to the high levels of circulating leptin in these subjects. This hypothesis was supported by data from obese rodents with hypothalamic lesions 19 and from the db=db mice which exhibit a mutated Ob-Rb and a normal expression of the splice forms. 20 In these models, adipocyte leptin mRNA expression was shown to be increased. Moreover, in humans with obesity, although large interindividual variations have been observed for a given body fat content, leptin expression and secretion by adipose tissue increased proportionally to the degree of fatness, 21 suggesting a metabolic inefficacy of leptin following chronic hyperleptinemia, 22 in keeping with the concept of hormonal resistance. The patients with the leptin receptor mutation were not characterized by an overexpression of ob gene in subcutaneous fat, as could be expected. There was even a tendency for a lower expression related to their degree of body fat mass when compared to ten morbidly obese women. The very high circulating levels of leptin in the blood of these patients may mostly arise from a change in the half-life of the hormone due to its trapping by the soluble truncated receptor. 9 This result strongly argues for the absence of a direct feedback loop in the control of ob gene expression in human adipose tissue. This conclusion suggests that the concept of leptin resistance to explain the increased plasma concentration and mRNA levels of leptin in obesity may be not entirely relevant. It is likely that the expression of leptin is mostly dependent upon the adipocyte cell size and differentiation, as has been reported in other studies. 23 In addition to its central effects, recent data in mice suggest that changes in leptin concentrations affect the expression of several key genes in adipose tissue. This could be due either to a direct action of leptin on adipocyte 5 or to a response to its central action. These changes in master gene expression could constitute the molecular basis of leptin action in the adaptation of adipose tissue functions to nutritional changes. The expression of the transcription factors SREBP1c and PPARg is reduced in leptin deficient ob=ob animals. A direct role of leptin on SREBP1c expression was suggested in gene expression profiling studies. 5, 24 In humans, limited data are available, but it has been shown Gene expression in absence of leptin signaling K Clément et al that PPARg gene expression was decreased in adipose tissue of obese women after weight loss 25 -27 whereas the levels of C=EBPa mRNAs remain unchanged. 27 The mRNA expression of SREBP1c is reduced in adipose tissue of obese individuals, 16 and increased upon weight reduction. 28 It is unclear whether the observed variations in adipose tissue gene expression after food restriction and=or weight loss are related to changes in leptin levels. The study of gene expression in subjects lacking the leptin signal aimed at verifying whether leptin could participate in the regulation of these adipose transcription key factors. We further suggested that a chronic defect of leptin signaling could be equivalent to a 'starvation-like' metabolic situation. According to this hypothesis, changes in gene expression in those patients would mimic those of subjects submitted to nutritional situations where leptin decreases (starvation or diet restriction).
Our findings clearly indicate that there was no major difference in the expression levels of the investigated genes in subcutaneous adipose tissue in morbidly obese women lacking the leptin signal. These results suggest that leptin does not play a critical role in the regulation of the expression of the tested adipose gene in obese individuals, although it could not be ruled out that counter-regulatory mechanisms that overcome leptin signal deficiency have occurred in patients with the leptin receptor mutation. In addition, the changes in adipose gene expression observed after diet restriction and=or weight loss may not be related to a direct effect of changes in leptin action. Altogether, these results are in agreement with the recent demonstration that leptin does not affect the important metabolic functions of cultured human adipocytes, 29 suggesting that there is no direct local action of leptin in human adipose tissue, in contrast to animal data. The observation that SREBP1c mRNA expression was in the normal range in leptin receptor deficient subjects and that there was no correlation between SREBP1c and ob gene expression also do not support a direct transcriptional link between leptin and SREBP1c as it was suggested from experiments in adipose tissue of ob=ob mice. 5 However, it was shown that the activity of SREBP-1c might also be regulated at posttranscriptional levels. 30 Our study does not exclude the possibility that leptin may directly or indirectly contribute to the posttranscriptional activities of SREBP-1c as well as of other tested gene products. To test this hypothesis, the determination of the protein levels encoded by the tested genes would be required. Of interest, hepatocyte-specific deletion of the leptin receptor was not associated with major phenotypic modification in mice. The liver gene expression, and the protein levels were not characterized in those mice but this study does not claim a potential direct role for leptin on liver metabolism, another key tissue involved in body weight regulation. 31 In conclusion, we demonstrate that the expression levels of key genes was not altered in the subcutaneous adipose tissue of extremely obese girls carrying a loss of function mutation of the leptin receptor when compared to morbidly obese women. The expression of the ob gene remained in the normal range, arguing against a negative feedback loop in the regulation of leptin expression in humans. Moreover, the expression of several genes known to be dependant on the nutritional status and=or affected during obesity was not altered in fat of patients with complete absence of leptin signal, suggesting that leptin, directly or indirectly, is not a major contributor to their in vivo transcriptional regulation. This work revealed additional differences between rodents and humans in the regulation of adipose tissue function and leptin action.
